Physician profile
Robert Paul
NPI 1538160643
$851.92
in general payments reported to CMS, 2019-2025
11 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $154 · 2022: $77.07 · 2023: $142 · 2024: $336 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $621.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $278.52 | 2021-2024 | Lifevest |
| Atricure, INC. | $156.70 | 2022-2024 | |
| Edwards Lifesciences Corporation | $146.92 | 2024-2025 | Evoque |
| Getinge USA Sales, LLC | $50.75 | 2024 | Cardioroot, Vasoview Hemopro 2 |
| Nevro Corp. | $43.91 | 2024 | Senza |
| Abiomed | $41.98 | 2023-2025 | Impella |
| Medtronic, INC. | $41.68 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $24.54 | 2022 | |
| Becton, Dickinson and Company | $24.04 | 2025 | Hemosphere |
| Globus Medical, INC. | $22.61 | 2025 | Omnia |
| Livanova USA, INC. | $20.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Paul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.